{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:28:53Z","timestamp":1761017333342,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/07559-3"],"award-info":[{"award-number":["2013\/07559-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.seizure.2021.02.023","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T12:16:42Z","timestamp":1614169002000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0694-9423","authenticated-orcid":false,"given":"Ang\u00e9lica","family":"Lizcano-Meneses","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-276X","authenticated-orcid":false,"given":"Nancy","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"von Glehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-754X","authenticated-orcid":false,"given":"Renata","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"de Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Yassuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriel S.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-8572","authenticated-orcid":false,"given":"Jos\u00e9 Wiliam","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-9205","authenticated-orcid":false,"given":"Leonilda M.B.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-9568","authenticated-orcid":false,"given":"Fernando","family":"Cendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.02.023_bib0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2021.02.023_bib0010","first-page":"1","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions","volume":"00","author":"Steriade","year":"2020","journal-title":"Epilepsy"},{"key":"10.1016\/j.seizure.2021.02.023_bib0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0020","first-page":"1","article-title":"Seizure specificities in patients with antibody-mediated autoimune encephalitis","volume":"00","author":"Vogrig","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.02.023_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-444-63432-0.00013-X","article-title":"Autoimmune epilepsy","volume":"133","author":"Britton","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens-pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.seizure.2021.02.023_bib0050","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2011-301237","article-title":"Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition","volume":"83","author":"Zuliani","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2021.02.023_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long\u2010term outcome in patients with anti\u2010NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2021.02.023_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.seizure.2021.02.023_bib0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/epi.13797","article-title":"Predictive models in the diagnosis and treatment of autoimmune epilepsy","volume":"58","author":"Dubey","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.02.023_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.02.023_bib0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/acn3.520","article-title":"Seizure semiology: an important clinical clue to the diagnosis of autoimmune epilepsy","volume":"5","author":"Lv","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1684\/epd.2017.0946","article-title":"Refractory chronic epilepsy associated with neuronal auto-antibodies: could perisylvian semiology be a clue?","volume":"19","author":"Gillinder","year":"2017","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2021.02.023_bib0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2018.06.021","article-title":"Electroclinical features of seizures associated with autoimmune encephalitis","volume":"60","author":"Steriade","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.02.023_bib0090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","article-title":"Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series","volume":"86","author":"Dogan Onugoren","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2021.02.023_bib0095","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.02.023_bib0100","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/brain\/awz094","article-title":"The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies","volume":"142","author":"van Coevorden-Hameete","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2021.02.023_bib0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.02.023_bib0115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.seizure.2014.04.009","article-title":"Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications","volume":"23","author":"Lilleker","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.02.023_bib0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","article-title":"Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies","volume":"30","author":"Malter","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.02.023_bib0125","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2021.02.023_bib0130","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2021.02.023_bib0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","article-title":"Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis","volume":"103","author":"Bernal","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.02.023_bib0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2021.02.023_bib0150","first-page":"55","article-title":"Anti-NMDAR encephalitis: a rare cause of status epilepticus and chorea in children","volume":"19","author":"Lizcano","year":"2013","journal-title":"J Epilepsy Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.seizure.2021.02.023_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0160","first-page":"1","article-title":"Continuous EEG findings in autoimmune encephalitis","volume":"00","author":"Moise","year":"2019","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0165","first-page":"287","article-title":"Autoimmune encephalitis","volume":"49","author":"Goodfellow","year":"2019","journal-title":"JR Coll Phys Edinb"},{"key":"10.1016\/j.seizure.2021.02.023_bib0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2010.09.012","article-title":"Anti-NMDA-receptor encephalitis: a severe, multistage, tratable disorder presenting with psychosis","volume":"231","author":"Wandinger","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.seizure.2021.02.023_bib0175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2021.02.023_bib0180","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.seizure.2021.02.023_bib0185","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10072-019-3729-7","article-title":"Peculiar EEG signatures, ictal drinking and long\u2010term follow\u2010up in anti\u2010 LGI1 encephalitis","volume":"40","author":"Vogrig","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.seizure.2021.02.023_bib0190","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti\u2010LGI1 encephalitis: clinical syndrome and long\u2010term follow\u2010up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.02.023_bib0195","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1\u2010antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2021.02.023_bib0200","doi-asserted-by":"crossref","DOI":"10.21767\/2171-6625.S10004","article-title":"Extreme delta brushes in pediatric anti-N-methyl-D-aspartate receptor encephalitis","author":"Montenegro","year":"2015","journal-title":"J Neurol Neurosci"},{"issue":"1","key":"10.1016\/j.seizure.2021.02.023_bib0205","first-page":"17","article-title":"Clinical, EEG and MRI evolution in Creutzfeldt-Jakob disease","volume":"22","author":"Lizcano","year":"2016","journal-title":"JECN"},{"key":"10.1016\/j.seizure.2021.02.023_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","article-title":"CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis","volume":"29","author":"Wang","year":"2015","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2021.02.023_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17925\/ENR.2013.08.01.31","article-title":"Autoimmune encephalitis","volume":"8","author":"Leypoldt","year":"2013","journal-title":"Eur Neurol Rev"},{"issue":"May-June 3","key":"10.1016\/j.seizure.2021.02.023_bib0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5698\/1535-7511.17.3.134","article-title":"\u201cAutoimmune epilepsy\u201d: encephalitis with autoantibodies for epileptologist","volume":"17","author":"Bien","year":"2017","journal-title":"Epilepsy Curr"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:01:37Z","timestamp":1761012097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":44,"alternative-id":["S1059131121000571"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.02.023","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}